Arrhythmia drug tied to cancer risk in men, study finds

04/8/2013 | MedPage Today (free registration)

An analysis of data from a health database in Taiwan found that men who took the antiarrhythmia drug amiodarone had a nearly 20% increased risk of developing cancer compared with the general population. The risk was 46% greater among men with extensive exposure to the drug. Women, however, did not seem to have a higher risk, researchers reported in the journal Cancer.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY